Artboard article
- NPR.org (2020)

President Trump is on day two of a planned 5-day course of remdesivir. The medication, approved for treating COVID-19, works by making it harder for the coronavirus to replicate within the body.

saved by: FoundryBase
updated 16 days ago
Visibility: Public (all visitors)


Comments

No comments yet. Be the first to comment!

MORE RESOURCES FROM SOURCE

More in FoundryBase from   NPR.org

Related Chunks

Related chunks with this resource

This Article can be found in 1 chunk